Draft Research Plan
Interventions to Prevent Falls in Community-Dwelling Older Adults
April 21, 2022
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
This document is available for Public Comments until May 18, 2022 11:59 PM EDT
In an effort to maintain a high level of transparency in our methods, we open our Draft Research Plan to a public comment period before we publish the final version.Leave a Comment >>
- Do interventions to prevent falls in community-dwelling older adults at average or increased risk reduce falls, falls-related morbidity, or mortality?
- How is “increased risk” defined in the included trials?
- Do interventions to prevent falls in community dwelling older adults at average or increased risk result in any adverse effects?
Contextual Questions will not be systematically reviewed and are not shown in the Analytic Framework.
- What is the prognostic accuracy of falls risk assessment tools that are feasible for administration in primary care?
The Proposed Research Approach identifies the study characteristics and criteria that the Evidence-based Practice Center will use to search for publications and to determine whether identified studies should be included or excluded from the Evidence Review. Criteria are overarching as well as specific to each of the key questions (KQs).
|Aim||Trials with the primary or secondary aim of reducing falls or falls-related injuries||Comparative effectiveness trials of fall interventions|
|Population||Community-dwelling, ambulatory adults age 65 years or older at average or increased risk for falls||Trials conducted exclusively in populations living in special settings outside of the community (e.g., hospitals, nursing or care homes, rehabilitation centers, or other long-term care facilities)
Trials conducted exclusively in special populations (e.g., adults with neurocognitive disorders, such as moderate to severe dementia or Parkinson’s disease) in which interventions may be considered disease management
Trials conducted exclusively in a population with pre-existing social ties
Interventions that are primary care-feasible or referable
Categories of included interventions:
Interventions may be delivered alone or in combination
Categories of excluded interventions:
|Comparators||Placebo, minimal control (i.e., provision of education via written materials, video, or lecture), or usual care||Active comparators|
KQ 2: Harm outcomes as reported in studies
KQ 2: Minor adverse events that are reported using nonvalidated, nongeneralizable measures
|Followup||Minimum of 6 months followup|
|Study Designs||Randomized, controlled trials||Editorials, letters, systematic and nonsystematic reviews, opinions, nonrandomized studies of interventions, convenience surveys, and qualitative studies|
|Setting||Interventions conducted in primary care or that are referable from primary care|
|Country||Countries categorized as “Very High” on the 2019 Human Development Index (as defined by the United Nations Development Programme)||Countries that are not categorized as “Very High” on the 2019 Human Development Index|
|Language||English only||Non-English language publications|
|Quality||Fair or good, according to design-specific criteria||Poor, according to design-specific criteria|